VKORC1 encodes an enzyme that recycles vitamin K and determines sensitivity to anticoagulants like warfarin. Fatigue is not a direct effect of VKORC1 variants, but can arise indirectly: if you take warfarin, certain VKORC1 polymorphisms increase sensitivity, raising bleeding risk and potentially causing anemia-related fatigue. Vitamin K deficiency (rare) could also contribute to tiredness. Evidence for a direct VKORC1–fatigue link without medication is weak. If you are on warfarin, monitor INR regularly and discuss fatigue with your doctor. If you only have genetic data and no anticoagulant therapy, no specific action is needed. Be cautious with vitamin K2 supplements (e.g., in D3+K2 products) as they can counteract warfarin. Evidence: strong for warfarin dosing, weak for fatigue as a standalone symptom.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-72b8adf75bde21adc7578de3